Department of Neurology, Philipps University, Rudolf-Bultmann Str. 8, 35033, Marburg, Germany.
J Neurol. 2011 Apr;258(4):549-58. doi: 10.1007/s00415-010-5865-0. Epub 2010 Dec 22.
Progressive supranuclear palsy (PSP) is a tauopathy, presenting clinically most often with a symmetrical akinetic-rigid syndrome, postural instability, supranuclear gaze palsy and frontal dementia. In the absence of reliably validated biomarkers, the diagnosis of PSP in vivo is presently based on clinical criteria, which to date do not include supporting imaging findings, as is accepted for other neurodegenerative diseases. However, data from conventional magnetic resonance imaging (MRI) and various advanced MRI techniques including magnetic resonance volumetry, voxel-based morphometry, diffusion-weighted and diffusion-tensor imaging, magnetization transfer imaging and proton resonance spectroscopy suggest that MRI can contribute valuable information for the differential diagnosis of PSP. We review here the presently published literature concerning MRI in PSP and discuss the potential role of MRI in differentiating PSP from other parkinsonian syndromes.
进行性核上性麻痹(PSP)是一种tau 病,临床上最常表现为对称的无动性僵硬综合征、姿势不稳、核上性眼球运动障碍和额痴呆。在缺乏可靠验证的生物标志物的情况下,目前 PSP 的体内诊断基于临床标准,迄今为止,这些标准不包括支持性影像学发现,这与其他神经退行性疾病的情况不同。然而,来自常规磁共振成像(MRI)和各种先进 MRI 技术的数据,包括磁共振容积成像、体素形态计量学、弥散加权和弥散张量成像、磁化传递成像和质子磁共振波谱,表明 MRI 可以为 PSP 的鉴别诊断提供有价值的信息。我们在此回顾了目前关于 PSP 中 MRI 的文献,并讨论了 MRI 在区分 PSP 与其他帕金森综合征方面的潜在作用。